A Highly Portable Device for Assessment of Mild Traumatic Brain Injury in

Status Enrolling by invitation

Clinical Trial Summary

The purpose of this study is to develop a highly portable, ruggedized diagnostic tool for concussion, EyeBOX Lens (EBLens), that can be utilized in deployed field and far-forward settings. The EBLens will be based on a concussion diagnostic algorithm from the FDA cleared EyeBOX device, developed by Oculogica, and eye-tracking data collected from a wearable set of eye-tracking glasses, developed by Adhawk Microsystems. Once the EBLens is prototyped, an algorithm for diagnosing concussion will be developed that is specifically appropriate for the EBLens via a case-control clinical study comparing 100 concussed to 100 non-concussed subjects (Phase I). Participants, age 18-35 years, will be recruited from the KACH research team and affiliated providers and clinical sites. Concussed individuals will be assessed within 72 hours of concussion. Demographics, basic medical history, symptom severity, a visio-vestibular exam and the EBLens scan will be collected on both injured cases and uninjured controls at a single time point. The algorithm and the EBLens will be validated in a subsequent, prospective cohort validation study (Phase II) designed for FDA submission. The correlation of the EBLens output with resolution of symptoms will also be observed in longitudinal follow-up of concussed participants in the validation study. The participant population for this study will be cadets recruited from the USMA and young athletes recruited from affiliated sites during baseline concussion testing. Participants will be assessed at baseline at the start of their academic year or sports season. Those participants who experience a concussive injury will be assessed again at three time points; 1) within 72 hours of injury, 2) weekly until and at the time of initiation of a graded return to activity protocol, and 3) upon clearance for unrestricted RTP/RTD.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05527041
Study type	Observational
Source	Oculogica, Inc.
Contact
Status	Enrolling by invitation
Phase
Start date	July 1, 2023
Completion date	September 26, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04372797` - Standardized Instruments to Provide Diagnostic and Prognostic Information in Mild Traumatic Brain Injury (mTBI)	N/A
Completed	`NCT01903525` - DHA For The Treatment of Pediatric Concussion Related to Sports Injury	Phase 1
Completed	`NCT01847040` - Deployment Related Mild Traumatic Brain Injury (mTBI)
Completed	`NCT03678077` - Trends in Cohabitation Status, Academic Achievement and Socio-economic Indicators After Mild Traumatic Brain Injury
Recruiting	`NCT05682677` - Combined Neuromodulation and Cognitive Training for Post-mTBI Depression	N/A
Terminated	`NCT03345550` - OPTIMA-TBI Pilot Study	Phase 2
Completed	`NCT05095012` - RECOVER Clinical Pathway for Pediatric Concussion	N/A
Recruiting	`NCT05886400` - The Effects of Environmental Distractions on SCAT6 Outcomes	N/A
Recruiting	`NCT05262361` - Persistent Post-Concussion Symptoms With Convergence Insufficiency	N/A
Active, not recruiting	`NCT03892291` - Objective Dual-task Turning Measures for Return-to-duty Assessments
Completed	`NCT03688984` - Treatment of Insomnia for Adolescents With Mild Traumatic Brain Injury	N/A
Completed	`NCT02057081` - Multifamily Group to Reduce Marital Conflict and Disability in Veterans With mTBI	N/A
Recruiting	`NCT06233851` - t-BIOMAP : Prospective Paediatric Cohort Study of Blood Biomarkers in mTBI
Completed	`NCT02844946` - One-Day Life Skills Workshop for Veterans With TBI, Pain and Psychopathology	N/A
Completed	`NCT04641767` - BIOmarkers of TRAumatic Brain Injury Spain (BIOTRABIS)
Recruiting	`NCT06112093` - Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches	N/A
Recruiting	`NCT03819608` - Neuromodulation and Neurorehabilitation for mTBI Plus PTSD	N/A
Withdrawn	`NCT00580918` - Functional MRI Study of Attention in Normal Controls and Traumatic Brain Injured Patients
Completed	`NCT03319966` - Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury
Recruiting	`NCT03846830` - Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Highly Portable Device for Assessment of Mild Traumatic Brain Injury in Deployed and Far-Forward Settings

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms